It has been shown that statin therapy lowers CRP and/or circulating pro-inflammatory cytokines’ levels in patients with hypercholesterolemia [21,22] and familial combined hyperlipidemia [23]. This evidence concerns the gene CRP and familial hypercholesterolemia.